R&D investments for the development of cell-based products are other factors expected to
support growth of the cell expansion market. According to a study published in NIH report,
around 500,000 people benefit from a transplant each year using regenerative medicine in the
U.S. Increasing R&D expenditure by several companies for the development of new therapeutic
products and availability of untapped growth opportunities are expected to drive the cell
expansion market in Asia Pacific. Biotechnology merger and acquisition (M&A) activities have
also experienced a boost in the region. According to investment bank China Renaissance, in
2016, 37 pharmaceutical and biotech M&A deals worth US$ 6.8 billion were closed in China.
Major industry players use merger and acquisitions as their major growth strategy
Key players operating in the cell expansion market include Becton, Dickinson and Company,
Beckman Coulter, Inc., Corning, Inc., GE Healthcare, Lonza, Merck KGaA (Sigma-Aldrich Co.
LLC), Miltenyi Biotec, Thermo Fisher Scientific, Inc., Terumo BCT, Inc., and Stemcell
Technologies, Inc. In July 2016, GE Healthcare acquired Biosafe SA, a Swiss company that
manufactures instruments that recover stem cells and help in various other cell processing
procedures related to personalized medicine. This acquisition will help GE Healthcare to grow
the cells in the sample for appropriate dose sizes.
Browse Complete Report For More Information @
https://www.coherentmarketinsights.com/ongoing-insight/cell-expansion-market-1293
About Coherent Market Insights
Coherent Market Insights is a prominent market research and consulting firm offering action-
ready syndicated research reports, custom market analysis, consulting services, and competitive
analysis through various recommendations related to emerging market trends, technologies, and
potential absolute dollar opportunity.
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com